NEW YORK (GenomeWeb) — IntegraGen announced today that it has signed an agreement giving Laboratoire Cerba the right to develop a tumor expression test based on its microRNA biomarker miR-31-3p.
Get the full story This story is free
for registered users
Registering provides access to this and other free content.
Already have an account?